S Polakoff. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Carrier State/epidemiologyHepatitis B/epidemiologyHepatitis B/prevention & controlHepatitis B Antigens/isolation & purificationHumansImmunodiffusionImmunoglobulins/therapeutic useMass ScreeningRenal Dialysis/adverse effects
Substances: See more » Hepatitis B AntigensImmunoglobulins
Year: 1971 PMID: 4997832 PMCID: PMC2467220 DOI: 10.1136/pgmj.47.549.501
Source DB: PubMed Journal: Postgrad Med J ISSN: 0032-5473 Impact factor: 2.401